Joseph R. Moskal
Corporate Officer/Principal bei Northwestern University
Profil
Joseph R.
Moskal was the founder of Naurex, Inc. (founded in 2006) and Aptinyx, Inc. (founded in 2015), where he held the title of Chief Scientific Officer.
He is currently the Director-Falk Center for Molecular Therapeutics at Northwestern University since 2013.
Previously, he worked as the Director-Neurosurgery Laboratories at Albert Einstein College of Medicine, Inc. Dr. Moskal completed his undergraduate and doctorate degrees at the University of Notre Dame.
Aktive Positionen von Joseph R. Moskal
Unternehmen | Position | Beginn |
---|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Joseph R. Moskal
Unternehmen | Position | Ende |
---|---|---|
Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
APTINYX | Gründer | - |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Gründer | - |
Ausbildung von Joseph R. Moskal
University of Notre Dame | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
APTINYX | Health Technology |
Private Unternehmen | 1 |
---|---|
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |